Had 0 3 0 3 O
at 4 6 4 6 O
least 7 12 7 12 O
14 13 15 13 15 B-lower_bound
days 16 20 16 20 I-lower_bound
for 21 24 21 24 O
prior 25 30 25 30 B-treatment
treatment 31 40 31 40 I-treatment
to 41 43 41 43 O
clear 44 49 44 49 O
the 50 53 50 53 O
body 54 58 54 58 O
before 59 65 59 65 O
initiation 66 76 66 76 O
of 77 79 77 79 O
DS-3201b 80 88 80 88 O
administration 89 103 89 103 O
( 104 105 104 105 O
except 105 111 105 111 O
for 112 115 112 115 O
hydroxyurea 116 127 116 127 B-treatment
that 128 132 128 132 O
needs 133 138 133 138 O
only 139 143 139 143 O
2 144 145 144 145 O
days 146 150 146 150 O
for 151 154 151 154 O
clearance 155 164 155 164 O
) 164 165 164 165 O

Had 0 3 166 169 O
major 4 9 170 175 B-treatment
surgery 10 17 176 183 I-treatment
within 18 24 184 190 O
4 25 26 191 192 B-upper_bound
weeks 27 32 193 198 I-upper_bound
before 33 39 199 205 O
study 40 45 206 211 O
drug 46 50 212 216 O
treatment 51 60 217 226 O

Has 0 3 227 230 O
AML 4 7 231 234 B-cancer
or 8 10 235 237 O
ALL 11 14 238 241 B-cancer
and 15 18 242 245 O
failed 19 25 246 252 O
any 26 29 253 256 O
prior 30 35 257 262 B-treatment
induction 36 45 263 272 I-treatment
therapy 46 53 273 280 I-treatment
regimen 54 61 281 288 O
or 62 64 289 291 O
have 65 69 292 296 O
relapsed 70 78 297 305 O
after 79 84 306 311 O
prior 85 90 312 317 B-treatment
therapy 91 98 318 325 I-treatment

Has 0 3 326 329 O
Eastern 4 11 330 337 B-clinical_variable
Cooperative 12 23 338 349 I-clinical_variable
Oncology 24 32 350 358 I-clinical_variable
Group 33 38 359 364 I-clinical_variable
( 39 40 365 366 I-clinical_variable
ECOG 40 44 366 370 I-clinical_variable
) 44 45 370 371 I-clinical_variable
performance 46 57 372 383 I-clinical_variable
status 58 64 384 390 I-clinical_variable
0 65 66 391 392 B-lower_bound
- 66 67 392 393 O
2 67 68 393 394 B-upper_bound

Has 0 3 395 398 O
a 4 5 399 400 O
life 6 10 401 405 B-clinical_variable
expectancy 11 21 406 416 I-clinical_variable
of 22 24 417 419 O
at 25 27 420 422 O
least 28 33 423 428 O
3 34 35 429 430 B-lower_bound
months 36 42 431 437 I-lower_bound

Has 0 3 438 441 O
a 4 5 442 443 O
second 6 12 444 450 O
concurrent 13 23 451 461 O
active 24 30 462 468 O
primary 31 38 469 476 B-cancer
malignancy 39 49 477 487 I-cancer
such 50 54 488 492 O
as 55 57 493 495 O
solid 58 63 496 501 B-cancer
tumor 64 69 502 507 I-cancer
or 70 72 508 510 O
lymphoma 73 81 511 519 B-cancer
under 82 87 520 525 O
active 88 94 526 532 O
treatment 95 104 533 542 B-treatment

Has 0 3 543 546 O
an 4 6 547 549 O
uncontrolled 7 19 550 562 B-chronic_disease
infection 20 29 563 572 I-chronic_disease
requiring 30 39 573 582 O
intravenous 40 51 583 594 B-treatment
antibiotics 52 63 595 606 I-treatment
, 63 64 606 607 O
antivirals 65 75 608 618 B-treatment
, 75 76 618 619 O
or 77 79 620 622 O
antifungals 80 91 623 634 B-treatment
, 91 92 634 635 O
known 93 98 636 641 O
human 99 104 642 647 B-chronic_disease
immunodeficiency 105 121 648 664 I-chronic_disease
virus 122 127 665 670 I-chronic_disease
infection 128 137 671 680 I-chronic_disease
, 137 138 680 681 O
or 139 141 682 684 O
tested 142 148 685 691 O
positive 149 157 692 700 O
for 158 161 701 704 O
active 162 168 705 711 B-chronic_disease
hepatitis 169 178 712 721 I-chronic_disease
B 179 180 722 723 I-chronic_disease
or 181 183 724 726 I-chronic_disease
C 184 185 727 728 I-chronic_disease
infection 186 195 729 738 I-chronic_disease

Has 0 3 739 742 O
presence 4 12 743 751 O
of 13 15 752 754 O
central 16 23 755 762 O
nervous 24 31 763 770 O
system 32 38 771 777 O
( 39 40 778 779 O
CNS 40 43 779 782 O
) 43 44 782 783 O
involvement 45 56 784 795 O
of 57 59 796 798 O
leukemia 60 68 799 807 B-cancer
or 69 71 808 810 O
a 72 73 811 812 O
history 74 81 813 820 O
of 82 84 821 823 O
CNS 85 88 824 827 B-cancer
leukemia 89 97 828 836 I-cancer

Has 0 3 837 840 O
prolonged 4 13 841 850 O
corrected 14 23 851 860 O
QT 24 26 861 863 B-clinical_variable
interval 27 35 864 872 I-clinical_variable
by 36 38 873 875 I-clinical_variable
Fridericia 39 49 876 886 I-clinical_variable
's 49 51 886 888 I-clinical_variable
method 52 58 889 895 I-clinical_variable
( 59 60 896 897 I-clinical_variable
QTcF 60 64 897 901 I-clinical_variable
) 64 65 901 902 I-clinical_variable
at 66 68 903 905 O
rest 69 73 906 910 O
, 73 74 910 911 O
where 75 80 912 917 O
the 81 84 918 921 O
mean 85 89 922 926 O
QTcF 90 94 927 931 B-clinical_variable
interval 95 103 932 940 I-clinical_variable
is 104 106 941 943 O
> 107 108 944 945 O
450 109 112 946 949 B-lower_bound
milliseconds 113 125 950 962 I-lower_bound
( 126 127 963 964 I-lower_bound
ms 127 129 964 966 I-lower_bound
) 129 130 966 967 I-lower_bound
based 131 136 968 973 O
on 137 139 974 976 O
triplicate 140 150 977 987 B-treatment
electrocardiograms 151 169 988 1006 I-treatment
( 170 171 1007 1008 I-treatment
ECGs 171 175 1008 1012 I-treatment
) 175 176 1012 1013 I-treatment

Has 0 3 1014 1017 O
received 4 12 1018 1026 O
concomitant 13 24 1027 1038 B-treatment
treatment 25 34 1039 1048 I-treatment
with 35 39 1049 1053 O
a 40 41 1054 1055 O
strong 42 48 1056 1062 O
inhibitor 49 58 1063 1072 O
or 59 61 1073 1075 O
inducer 62 69 1076 1083 O
of 70 72 1084 1086 O
cytochrome 73 83 1087 1097 B-clinical_variable
P450 84 88 1098 1102 I-clinical_variable
( 89 90 1103 1104 I-clinical_variable
CYP)3A4/5 90 99 1104 1113 I-clinical_variable
within 100 106 1114 1120 O
7 107 108 1121 1122 B-upper_bound
days 109 113 1123 1127 I-upper_bound
of 114 116 1128 1130 O
first 117 122 1131 1136 O
receipt 123 130 1137 1144 O
of 131 133 1145 1147 O
DS-3201b 134 142 1148 1156 B-treatment

Has 0 3 1157 1160 O
received 4 12 1161 1169 O
hematopoietic 13 26 1170 1183 B-treatment
stem 27 31 1184 1188 I-treatment
cell 32 36 1189 1193 I-treatment
transplantation 37 52 1194 1209 I-treatment
( 53 54 1210 1211 I-treatment
HSCT 54 58 1211 1215 I-treatment
) 58 59 1215 1216 I-treatment
within 60 66 1217 1223 O
60 67 69 1224 1226 B-upper_bound
days 70 74 1227 1231 I-upper_bound
of 75 77 1232 1234 O
the 78 81 1235 1238 O
first 82 87 1239 1244 O
dose 88 92 1245 1249 O
of 93 95 1250 1252 O
DS-3201b 96 104 1253 1261 B-treatment

Has 0 3 1262 1265 O
received 4 12 1266 1274 O
prior 13 18 1275 1280 B-treatment
treatment 19 28 1281 1290 I-treatment
with 29 33 1291 1295 O
enhancer 34 42 1296 1304 B-treatment
of 43 45 1305 1307 I-treatment
zeste 46 51 1308 1313 I-treatment
homolog 52 59 1314 1321 I-treatment
( 60 61 1322 1323 I-treatment
EZH 61 64 1323 1326 I-treatment
) 64 65 1326 1327 I-treatment
inhibitor 66 75 1328 1337 I-treatment

Has 0 3 1338 1341 O
refractory 4 14 1342 1352 O
nausea 15 21 1353 1359 O
and 22 25 1360 1363 O
vomiting 26 34 1364 1372 O
, 34 35 1372 1373 O
malabsorption 36 49 1374 1387 B-chronic_disease
, 49 50 1387 1388 O
biliary 51 58 1389 1396 O
shunt 59 64 1397 1402 O
, 64 65 1402 1403 O
significant 66 77 1404 1415 O
bowel 78 83 1416 1421 B-treatment
resection 84 93 1422 1431 I-treatment
, 93 94 1431 1432 O
graft 95 100 1433 1438 B-chronic_disease
versus- 101 108 1439 1446 I-chronic_disease
host 109 113 1447 1451 I-chronic_disease
disease 114 121 1452 1459 I-chronic_disease
( 122 123 1460 1461 I-chronic_disease
GVHD 123 127 1461 1465 I-chronic_disease
) 127 128 1465 1466 I-chronic_disease
significantly 129 142 1467 1480 O
affecting 143 152 1481 1490 O
gut 153 156 1491 1494 O
motility 157 165 1495 1503 O
or 166 168 1504 1506 O
absorption 169 179 1507 1517 O
, 179 180 1517 1518 O
or 181 183 1519 1521 O
any 184 187 1522 1525 O
other 188 193 1526 1531 O
condition 194 203 1532 1541 O
that 204 208 1542 1546 O
would 209 214 1547 1552 O
preclude 215 223 1553 1561 O
adequate 224 232 1562 1570 O
absorption 233 243 1571 1581 O
of 244 246 1582 1584 O
DS- 247 250 1585 1588 O
3201b 251 256 1589 1594 O
in 257 259 1595 1597 O
the 260 263 1598 1601 O
opinion 264 271 1602 1609 O
of 272 274 1610 1612 O
the 275 278 1613 1616 O
treating 279 287 1617 1625 O
physician 288 297 1626 1635 O
and/or 298 304 1636 1642 O
principal 305 314 1643 1652 O
investigator 315 327 1653 1665 O
( 328 329 1666 1667 O
PI 329 331 1667 1669 O
) 331 332 1669 1670 O

Has 0 3 1671 1674 O
substance 4 13 1675 1684 O
abuse 14 19 1685 1690 O
or 20 22 1691 1693 O
medical 23 30 1694 1701 B-chronic_disease
, 30 31 1701 1702 O
psychological 32 45 1703 1716 B-chronic_disease
, 45 46 1716 1717 O
or 47 49 1718 1720 O
social 50 56 1721 1727 B-chronic_disease
conditions 57 67 1728 1738 I-chronic_disease
that 68 72 1739 1743 O
, 72 73 1743 1744 O
in 74 76 1745 1747 O
the 77 80 1748 1751 O
opinion 81 88 1752 1759 O
of 89 91 1760 1762 O
the 92 95 1763 1766 O
Investigator 96 108 1767 1779 O
, 108 109 1779 1780 O
may 110 113 1781 1784 O
interfere 114 123 1785 1794 O
with 124 128 1795 1799 O
the 129 132 1800 1803 O
subject 133 140 1804 1811 O
's 140 142 1811 1813 O
participation 143 156 1814 1827 O
in 157 159 1828 1830 O
the 160 163 1831 1834 O
clinical 164 172 1835 1843 O
study 173 178 1844 1849 O
or 179 181 1850 1852 O
evaluation 182 192 1853 1863 O
of 193 195 1864 1866 O
the 196 199 1867 1870 O
clinical 200 208 1871 1879 O
study 209 214 1880 1885 O
results 215 222 1886 1893 O

Has 0 3 1894 1897 O
unresolved 4 14 1898 1908 O
toxicities 15 25 1909 1919 O
from 26 30 1920 1924 O
previous 31 39 1925 1933 O
anticancer 40 50 1934 1944 B-treatment
therapy 51 58 1945 1952 I-treatment

